This report provides exclusive insights into the COVID-19 impact on the Varicose Vein Treatment Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Varicose Vein Treatment Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Varicose Vein Treatment Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on
varicose vein treatment market provides in-depth analysis of segments and
sub-segments in the global as well as regional varicose vein treatment market.
The study also highlights the impact of drivers, restraints, and macro
indicators on the global and regional varicose vein treatment market over the
short term as well as long term. The report is a comprehensive presentation of
trends, forecast and dollar values of global varicose vein treatment market.
According to the report, the global varicose vein treatment market is projected
to grow at a CAGR of 4.8% over the forecast period of 2019-2025.
Varicose Veins are twisted and swollen veins in the legs. It is harmful to health which may lead to
venous static ulcers, thrombosis, venous hemorrhage or fungal and bacterial
infections. Varicose veins are treated with lifestyle changes and medical
procedures. There is various treatment available for the varicose vein which
includes, compression therapy, endothermal ablation, ultrasound-guided foam
sclerotherapy and surgery, transilluminated powered phlebectomy and many
The increasing prevalence of varicose vein and growing
awareness about varicose veins across the globe drives the growth of the
varicose vein treatment market over the forecast period. It is estimated that,
varicose veins affecting millions of Americans every year. Moreover, the availability
of innovative therapies and devices is another major factor in augmenting market
growth. ClariVein®OC is a specialty device used for the occlusion of
incompetent veins in patients with superficial venous reflux. This device is
fully disposable, minimally invasive, and can be efficiently used in an office
setting. Additionally, it offers several benefits includes faster recovery and
minimal post-operative pain. Moreover, the introduction of endovenous
cyanoacrylate glue to treat varicose veins is likely to enhance market demand.
For instance, under the Venaseal Closure System of Medtronic, uses endovenous
cyanoacrylate glue to seal off varicose veins and more than 100,000 patients
have been treated with the VenaSeal closure system around the world. Additionally,
the availability of technologically advanced varicose vein treatment devices,
growth in the geriatric population and increasing healthcare expenditure are
some factors supporting the growth of varicose vein treatment market over
the forecast period. However, the high cost of varicose vein treatment is
expected to hamper the growth of the market. Going further, companies operating
in this market are focusing on their production capabilities to manufacture
innovative compression garments and devices such as compression bandages,
self-adjustable velcro devices, compression stockings, and hybrid devices that
provide growth opportunities for the market. Compression garments and devices
are gaining popularity due to the increasing uses of these products after
varicose vein intervention.
Among the region, North America is expected to hold maximum
share in the global varicose vein treatment market owing to the increasing
prevalence of varicose veins and well-developed healthcare infrastructure. In
the North America region, the U.S. is accounted for the largest share in this
market owing to the accessibility of excellent reimbursement facilities.
Furthermore, it is predicted that there were 40 million peoples affected by
varicose vein in the US, with near about 50% of varicose vein patients having a
family history. However, Europe is accounted to register the highest growth
rate throughout the forecast period. This is due to the high adoption of
technologically advanced treatment and favorable government initiatives in this
region. Asia-Pacific is expected to witness the fastest growing region in this
market owing to increasing healthcare expenditure and a large patient pool.
The report on the global varicose vein treatment market covers segments
such as treatment type, product, and end user. On the basis of treatment type,
the sub-markets include sclerotherapy/adhesion injections, endovenous ablation,
ligation/stripping, and other product types. On the basis of product, the
sub-markets include compression devices/garments, ablation devices,
catheters/kits for sclerotherapy & adhesion injections, and other products.
On the basis of end user, the sub-markets include hospitals & ambulatory
surgical centers, specialty clinic, and other end-users.
The report provides profiles of the companies in the market
such as SIGVARIS GROUP, BSN medical GmbH, Teleflex Incorporated, Mylan N.V.,
DJO Global, Inc., WON TECH Co., Ltd., F Care Systems, VVT Medical, BTG
International Limited, and AngioDynamics, Inc.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of varicose vein
treatment market. Moreover, the study highlights current market trends and
provides forecast from 2019-2025. We also have highlighted future trends in the
market that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.